Koji Tsuta
Kansai Medical University · 526 works · 17,768 citations · h-index 65
Top works
- Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer
- Comprehensive genomic profiles of small cell lung cancer
- KIF5B-RET fusions in lung adenocarcinoma
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
- Identification of Genes Upregulated in ALK -Positive and EGFR/KRAS/ALK -Negative Lung Adenocarcinomas
- Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas
- STAT6 Immunohistochemistry Is Helpful in the Diagnosis of Solitary Fibrous Tumors
- EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan
- Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
- The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
- A Synthetic Lethality–Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1
- Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung
- ROS1-Rearranged Lung Cancer
- Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma
- Detection of EGFR Mutations in Archived Cytologic Specimens of Non-Small Cell Lung Cancer Using High-Resolution Melting Analysis
- Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases
- Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
- Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner
- Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.
- Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component